Nam Hoon Kim

20PUBLICATIONS
27CO-AUTHORS
Experimental methods in fluid flow, heat and mass transferEpidemiological modellingAnthropological geneticsEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Dec 09, 2025
Sodium-glucose cotransporter 2 inhibitor ameliorates thiazolidinedione-induced fluid retention through vascular leakage reduction in white adipose tissue.

Ji Yoon Kim, Hye-Min Jang, Hye-Jin Lee

|Jul 20, 2025
Fenofibrate therapy and risk of heart failure outcomes in patients with Type 2 diabetes: a propensity-matched cohort study.

Ji Yoon Kim, Nam Hoon Kim, Jiyoon Lee

|Jun 10, 2025
Lipoprotein(a) and Cardiovascular Risk in Asian Populations: A Comprehensive Review.

Jung A Kim, Nam Hoon Kim

|Jan 08, 2025
Glycemia Risk Index is Associated With Risk of Albuminuria Among Individuals With Type 1 Diabetes.

Ji Yoon Kim, Jee Hee Yoo, Nam Hoon Kim

|Jun 10, 2024
Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add-on therapy in drug-naïve patients with type 2 diabetes (TRIPLE-AXEL study): A multicentre, randomized, 104-week, open-label, active-controlled trial.

Nam Hoon Kim, Jun Sung Moon, Yong-Ho Lee

|Nov 29, 2023
Associations of omega-3 fatty acids vs. fenofibrate with adverse cardiovascular outcomes in people with metabolic syndrome: propensity matched cohort study.

Nam Hoon Kim, Ji Yoon Kim, Jimi Choi

Pageof 4

Frequent Collaborators

10 joint publications

Sin Gon Kim

7 joint publications

Ji Yoon Kim

4 joint publications

Jae Hyun Bae

4 joint publications

Kyoung Jin Kim